FBRX
Forte Biosciences, Inc. [FBRX] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
FBRX Stock Summary
Top 10 Correlated Stocks
FBRX
In the News
FBRX Financial details
Company Rating
-
Market Cap
26.32M
Income
-31.37M
Revenue
0
Book val./share
-
Cash/share
-
Dividend
-
Dividend %
-
Employees
9
Optionable
No
Shortable
Yes
Earnings
13 May 2024
P/E
-1.06
Forward P/E
-
PEG
-0.24
P/S
-
P/B
0.8
P/C
-
P/FCF
-1.36
Quick Ratio
6.18
Current Ratio
6.3
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
-1.16
EPS next Y
-
EPS next Q
-
EPS this Y
25%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-
Revenue last 5Y
-
Revenue Q/Q
-
EPS Q/Q
-38.46%
-
-
-
-
SMA20
-5.86%
SMA50
3.79%
SMA100
111.09%
Inst Own
-
Inst Trans
-
ROA
-63%
ROE
-89%
ROC
-0.77%
Gross Margin
-
Oper. Margin
-
Profit Margin
-
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
0.38-1.15
52W High
-
52W Low
-
RSI
40.4
Rel Volume
3.66
Avg Volume
34.26K
Volume
125.42K
Perf Week
-15.81%
Perf Month
-8.49%
Perf Quarter
97.93%
Perf Half Y
145.55%
-
-
-
-
Beta
1.655
-
-
Volatility
1.11%, 1.83%
Prev Close
-1.4%
Price
26.74
Change
-1.33%
Company Profile
- Volume Average 34.26K
- Market Capitalization 26.32M
- Employee 9
- CEO Dr. Paul A. Wagner Ph.D.
- Headquarters Dallas,TX,US
- IPO Date 2017-04-13
-
Website
https://www.fortebiorx.com 
Forte Biosciences, Inc. operates as a clinical-stage biopharmaceutical company in the United States. It is developing FB-102 program that addresses various autoimmune diseases, such as vitiligo and alopecia areata. The company is headquartered in Dallas, Texas.
